Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 1
1991 1
1992 2
1993 3
1995 3
1996 5
1997 2
1998 4
1999 2
2000 6
2001 3
2002 8
2003 9
2004 7
2005 6
2006 4
2007 7
2008 3
2009 2
2010 6
2011 4
2012 4
2013 8
2014 8
2015 10
2016 5
2017 13
2018 8
2019 5
2020 8
2021 6
2022 4
2023 3
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial.
Giugliano RP, Pedersen TR, Park JG, De Ferrari GM, Gaciong ZA, Ceska R, Toth K, Gouni-Berthold I, Lopez-Miranda J, Schiele F, Mach F, Ott BR, Kanevsky E, Pineda AL, Somaratne R, Wasserman SM, Keech AC, Sever PS, Sabatine MS; FOURIER Investigators. Giugliano RP, et al. Among authors: ott br. Lancet. 2017 Oct 28;390(10106):1962-1971. doi: 10.1016/S0140-6736(17)32290-0. Epub 2017 Aug 28. Lancet. 2017. PMID: 28859947 Free article. Clinical Trial.
Heart Failure and Fitness to Drive.
Carr DB, Ott BR. Carr DB, et al. Among authors: ott br. J Card Fail. 2020 Jul;26(7):564-565. doi: 10.1016/j.cardfail.2020.05.017. Epub 2020 Jun 6. J Card Fail. 2020. PMID: 32512216 No abstract available.
Cognition After Lowering LDL-Cholesterol With Evolocumab.
Gencer B, Mach F, Guo J, Im K, Ruzza A, Wang H, Kurtz CE, Pedersen TR, Keech AC, Ott BR, Sabatine MS, Giugliano RP; FOURIER Investigators. Gencer B, et al. Among authors: ott br. J Am Coll Cardiol. 2020 May 12;75(18):2283-2293. doi: 10.1016/j.jacc.2020.03.039. J Am Coll Cardiol. 2020. PMID: 32381158 Free article. Clinical Trial.
Pharmacotherapy of dementia with Lewy bodies.
Fernandez HH, Wu CK, Ott BR. Fernandez HH, et al. Among authors: ott br. Expert Opin Pharmacother. 2003 Nov;4(11):2027-37. doi: 10.1517/14656566.4.11.2027. Expert Opin Pharmacother. 2003. PMID: 14596656 Review.
Antidementia Medication Use in Nursing Home Residents.
Ott BR, Hollins C, Tjia J, Baek J, Chen Q, Lapane KL, Alcusky M. Ott BR, et al. J Geriatr Psychiatry Neurol. 2024 May;37(3):194-205. doi: 10.1177/08919887231202948. Epub 2023 Sep 16. J Geriatr Psychiatry Neurol. 2024. PMID: 37715795
Quality of Life measures for dementia.
Ready RE, Ott BR. Ready RE, et al. Among authors: ott br. Health Qual Life Outcomes. 2003 Apr 23;1:11. doi: 10.1186/1477-7525-1-11. Health Qual Life Outcomes. 2003. PMID: 12740036 Free PMC article. Review.
Driving and dementia: a review of the literature.
Brown LB, Ott BR. Brown LB, et al. Among authors: ott br. J Geriatr Psychiatry Neurol. 2004 Dec;17(4):232-40. doi: 10.1177/0891988704269825. J Geriatr Psychiatry Neurol. 2004. PMID: 15533995 Free PMC article. Review.
Preclinical Alzheimer's disease and longitudinal driving decline.
Roe CM, Babulal GM, Head DM, Stout SH, Vernon EK, Ghoshal N, Garland B, Barco PP, Williams MM, Johnson A, Fierberg R, Fague MS, Xiong C, Mormino E, Grant EA, Holtzman DM, Benzinger TLS, Fagan AM, Ott BR, Carr DB, Morris JC. Roe CM, et al. Among authors: ott br. Alzheimers Dement (N Y). 2017 Jan;3(1):74-82. doi: 10.1016/j.trci.2016.11.006. Alzheimers Dement (N Y). 2017. PMID: 28435853 Free PMC article.
163 results